{
  "drug_name": "Azithromycin",
  "tradename": "Zithromax, Z-Pak",
  "usage_and_dosing": {
    "general": [
      "Azithromycin is a macrolide antibiotic with a broad spectrum of activity against many aerobic and anaerobic gram-positive and gram-negative organisms.",
      "It is also active against some protozoa.",
      "For class-wide adverse effects, see Macrolides, Overview."
    ],
    "adult_dose": {
      "usual_dose": "500 mg po/IV x1, then 250 mg po/IV q24h",
      "note": "Dosing varies by indication"
    },
    "pediatric_dose": {
      "dose_age_gt_28_days": "10 mg/kg (max 500 mg) po/IV on day 1, then 5 mg/kg (max 250 mg) q24h",
      "max_day": "-"
    }
  },
  "renal_adjustment": {
    "half_life_normal": "68",
    "half_life_esrd": "No data",
    "dose_renal_function_normal": "500 mg po/IV q24h",
    "crcl_or_egfr": "No dosage adjustment",
    "hemodialysis": "No dosage adjustment",
    "capd": "No data",
    "crrt": "No data",
    "sled": "No data"
  },
  "hepatic_adjustment": {
    "mild_impairment_child_pugh_a": "No dosage adjustment",
    "moderate_impairment_child_pugh_b": "No dosage adjustment",
    "severe_impairment_child_pugh_c": "No dosage adjustment"
  },
  "adverse_effects": [
    "For complete class-wide adverse effects see Macrolides, Overview and for QTc prolongation, see QTc Interval Prolongation.",
    "Any of the macrolides may exacerbate muscle weakness in persons with myasthenia gravis."
  ],
  "pregnancy_risk": {
    "fda_risk_category": "No evidence of toxicity in humans or animals",
    "lactation": "Probably safe, monitor infant for GI toxicity.",
    "footnote": "Capital letter = Old FDA risk category; Text = New FDA risk category"
  },
  "antimicrobial_spectrum": {
    "preferred": [
        "Chlamydia trachomatis",
        "Haemophilus ducreyi",
        "Mycoplasma pneumoniae"
    ],
    "alternative": []
  },
  "pharmacology": {
    "pk_pd_index": "24-hr AUC/MIC",
    "preparations": "Tab (250, 500, 600 mg), Oral susp (100 mg/5 mL, 200 mg/5 mL), Injection",
    "food_recommendation": "Tab ± food, Susp no food",
    "oral_absorption_percent": "37",
    "tmax_hr": "2-3",
    "peak_serum_conc_ug_ml": "0.4 (500 mg po, SD)",
    "peak_urine_conc_ug_ml": "No data",
    "protein_binding_percent": "7-50",
    "volume_of_distribution_vd_l_kg": "31 L/kg",
    "avg_serum_half_life_hr": "68",
    "elimination": "Biliary, renal",
    "bile_penetration_percent": "High",
    "csf_blood_percent": "Low",
    "therapeutic_levels_in_csf": "No",
    "auc_ug_hr_ml": "10.3 (500 mg po, 0-72h)"
  },
  "major_drug_interactions": [
      {"drug": "Antacids (Al, Mg)", "effect": "↓ azithromycin", "management": "Separate administration by 2 hours"},
      {"drug": "Antiarrhythmics (Class IA/III)", "effect": "↑ QT interval", "management": "Avoid co-administration"},
      {"drug": "Atorvastatin", "effect": "↑ atorvastatin", "management": "Monitor"},
      {"drug": "Cyclosporine", "effect": "↑ cyclosporine", "management": "Monitor"},
      {"drug": "Digoxin", "effect": "↑ digoxin", "management": "Monitor"},
      {"drug": "Ergot alkaloids", "effect": "↑ ergot alkaloid", "management": "Avoid co-administration"},
      {"drug": "Lovastatin", "effect": "↑ lovastatin", "management": "Monitor"},
      {"drug": "Pimozide", "effect": "↑ pimozide", "management": "Avoid co-administration"},
      {"drug": "Simvastatin", "effect": "↑ simvastatin", "management": "Monitor"},
      {"drug": "Tacrolimus", "effect": "↑ tacrolimus", "management": "Monitor"},
      {"drug": "Theophylline", "effect": "↑ theophylline", "management": "Monitor"},
      {"drug": "Warfarin", "effect": "↑ INR", "management": "Monitor INR, adjust dosage"}
  ]
}
